All Pathways
Family MedicineManagement

Upper Respiratory Infection Management (IDSA/CDC)

Upper Respiratory Infection Management (IDSA/CDC): Upper Respiratory Symptoms → Primary Symptom Pattern → Pharyngitis/Sore Throat → Strep Test Result → ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Upper Respiratory Symptoms

    Cough, congestion, sore throat, rhinorrhea

    1. Decision

      Primary Symptom Pattern

      Determine syndrome

      1. Action

        Pharyngitis/Sore Throat

        Assess for Group A Strep

        • Use Centor/McIsaac criteria
        • Fever, tonsillar exudates, tender anterior cervical nodes, no cough
        • Score 0-1: No testing, symptomatic care
        • Score 2-3: Rapid strep test
        • Score 4+: Empiric treatment or test
        1. Decision

          Strep Test Result

          Rapid strep or culture

          1. Action

            GAS Pharyngitis

            Antibiotic treatment

            • Penicillin V 500mg BID x 10 days
            • Amoxicillin 500mg BID x 10 days
            • PCN allergy: Azithromycin 500mg day 1, 250mg days 2-5
            • Symptomatic improvement expected 24-48h
            1. Action

              Symptomatic Treatment

              All URI syndromes

              • Hydration and rest
              • Acetaminophen or ibuprofen for pain/fever
              • Topical/oral decongestants (<3 days)
              • Honey for cough (age >1 year)
              • Nasal saline irrigation
              1. Action

                Return Precautions

                When to seek care

                • Symptoms worsening after day 3
                • Not improved by day 10
                • High fever >102°F
                • Difficulty breathing
                • Severe headache, facial swelling
          2. Action

            Viral Pharyngitis

            Symptomatic care only

            • No antibiotics indicated
            • Salt water gargles
            • Lozenges, NSAIDs for pain
            • Most improve in 7 days
      2. Action

        Rhinosinusitis

        Viral vs bacterial distinction

        • <10 days: Likely viral
        • ≥10 days without improvement: Consider bacterial
        • Severe symptoms (high fever, facial pain) >3 days: Consider bacterial
        • Double-worsening: Improving then worse
        1. Decision

          Bacterial Sinusitis Criteria Met?

          Symptoms ≥10 days OR severe

          1. Action

            Bacterial Sinusitis Treatment

            Antibiotic options

            • First-line: Amoxicillin-clavulanate 875/125mg BID x 5-7 days
            • Alt: Doxycycline 100mg BID x 5-7 days
            • PCN allergy: Doxycycline or respiratory fluoroquinolone
            • Decongestants and saline rinses adjunctive
            1. Action

              Watchful Waiting Option

              Delayed prescribing strategy

              • Appropriate for mild bacterial sinusitis
              • Give prescription with instructions to fill if not better in 7 days
              • Reduces antibiotic use by 50%
              • Ensure patient understands worsening signs
      3. Action

        Acute Bronchitis

        Almost always viral

        • Cough predominant, may last 2-3 weeks
        • No pneumonia signs (focal findings, dyspnea)
        • Antibiotics NOT recommended
        • Cough suppressants, honey (adults)
        • Inhaler if bronchospasm present

Guideline Source

IDSA/CDC Principles of Judicious Antibiotic Prescribing

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address influenza-specific treatment
  • COVID-19 considerations not specifically addressed
  • Bacterial sinusitis antibiotic choice may vary by resistance patterns
  • Does not address immunocompromised patients
  • Watchful waiting requires patient education and safety-net

Applicable Regions

USAUUKEU

AU: eTG recommends similar conservative approach

UK: NICE supports delayed prescribing strategy

US: CDC antibiotic stewardship guidelines

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Upper Respiratory Infection Management (IDSA/CDC)?

The Upper Respiratory Infection Management (IDSA/CDC) is a management clinical algorithm for Family Medicine. It provides a structured decision tree to guide clinical decision-making, based on IDSA/CDC Principles of Judicious Antibiotic Prescribing.

What guideline is the Upper Respiratory Infection Management (IDSA/CDC) based on?

This algorithm is based on IDSA/CDC Principles of Judicious Antibiotic Prescribing (DOI: 10.7326/M16-1686).

What are the limitations of the Upper Respiratory Infection Management (IDSA/CDC)?

Known limitations include: Does not address influenza-specific treatment; COVID-19 considerations not specifically addressed; Bacterial sinusitis antibiotic choice may vary by resistance patterns; Does not address immunocompromised patients; Watchful waiting requires patient education and safety-net. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Upper Respiratory Infection Management (IDSA/CDC) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free